The latest round of FDA warning letters to food manufacturers, who are stepping over the line between marketing claims and health claims, provides a ringside seat into the daily judgment calls that communicators are often asked to weigh in on — if they know about them.
A March 5th PRweek editorial stated that communications pros should have prevented this latest round of FDA warnings, but what we will never know is did they try and were overruled, or were they ...